Cargando…

Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection

Detalles Bibliográficos
Autores principales:	Liu, Zezhong, Xia, Shuai, Wang, Xinling, Lan, Qiaoshuai, Xu, Wei, Wang, Qian, Jiang, Shibo, Lu, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105968/ https://www.ncbi.nlm.nih.gov/pubmed/32236815 http://dx.doi.org/10.1007/s12250-020-00214-5

Ejemplares similares

Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
por: Xia, Shuai, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus
por: Wang, Nan, et al.
Publicado: (2020)

The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin
por: Xia, Shuai, et al.
Publicado: (2020)

Generation of MERS-CoV Pseudotyped Viral Particles for the Evaluation of Neutralizing Antibodies in Mammalian Sera
por: Almasaud, Abdulrahman, et al.
Publicado: (2019)

A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome
por: Jiang, Shibo, et al.
Publicado: (2020)

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
por: Xia, Shuai, et al.
Publicado: (2020)

Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4
por: Xia, Shuai, et al.
Publicado: (2019)

The role of pseudotype neutralization assays in understanding SARS CoV-2
por: Cantoni, Diego, et al.
Publicado: (2021)

Chinese medical personnel against the 2019-nCoV
por: Feng, Zhan-hui, et al.
Publicado: (2020)

Origins of MERS-CoV, and lessons for 2019-nCoV
por: Ji, John S
Publicado: (2020)

An update on the 2019-nCoV outbreak
por: Ammad Ud Din, Mohammad, et al.
Publicado: (2020)

Pandemic potential of 2019-nCoV
por: Thompson, Robin
Publicado: (2020)

Emerging understandings of 2019-nCoV
por: The Lancet
Publicado: (2020)

Return of the Coronavirus: 2019-nCoV
por: Gralinski, Lisa E., et al.
Publicado: (2020)

2019-nCoV: Polite with children!
por: Caselli, Désirée, et al.
Publicado: (2020)

Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
por: Song, Fengxiang, et al.
Publicado: (2020)

Combining a Fusion Inhibitory Peptide Targeting the MERS-CoV S2 Protein HR1 Domain and a Neutralizing Antibody Specific for the S1 Protein Receptor-Binding Domain (RBD) Showed Potent Synergism against Pseudotyped MERS-CoV with or without Mutations in RBD
por: Wang, Cong, et al.
Publicado: (2019)

2019 Novel Coronavirus (2019-nCoV) Pneumonia
por: Liu, Peng, et al.
Publicado: (2020)

RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
por: Liu, Zezhong, et al.
Publicado: (2020)

Neutralization Assay with SARS-CoV-1 and SARS-CoV-2 Spike Pseudotyped Murine Leukemia Virions
por: Zheng, Yue, et al.
Publicado: (2020)

Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
por: Zheng, Yue, et al.
Publicado: (2021)

On the use of corticosteroids for 2019-nCoV pneumonia
por: Shang, Lianhan, et al.
Publicado: (2020)

Coronaphobia: Fear and the 2019-nCoV outbreak
por: Asmundson, Gordon J.G., et al.
Publicado: (2020)

2019-nCoV, fake news, and racism
por: Shimizu, Kazuki
Publicado: (2020)

Epitopes for a 2019-nCoV vaccine
por: Lucchese, Guglielmo
Publicado: (2020)

Unveiling the Origin and Transmission of 2019-nCoV
por: Xu, Yifei
Publicado: (2020)

2019-nCoV in context: lessons learned?
por: Kock, Richard A, et al.
Publicado: (2020)

IDM editorial statement on the 2019-nCoV
por: Shao, Yiming, et al.
Publicado: (2020)

Containing 2019-nCoV (Wuhan) coronavirus
por: Kaplan, Edward H.
Publicado: (2020)

Novel Coronavirus (2019-nCoV) in Disguise
por: Zhang, Qian, et al.
Publicado: (2020)

Potential treatment methods targeting 2019-nCoV infection
por: Zheng, Lu, et al.
Publicado: (2020)

Machine intelligence design of 2019-nCoV drugs
por: Gao, Kaifu, et al.
Publicado: (2020)

Ophthalmology Consultation Plan in the Context of 2019-nCoV
por: Song, Shuang, et al.
Publicado: (2021)

The pandemic characteristics of 2019-nCoV: case-control study for severity and geographic locations for 2019-nCoV epidemics worldwide
por: Ronchetti, Roberto, et al.
Publicado: (2020)

Comparison of Real‐Q 2019‐nCoV and DaAn Gene 2019‐nCoV polymerase chain reaction assays for the detection of SARS‐CoV‐2
por: Marembo, Takudzwa, et al.
Publicado: (2021)

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
por: Schmidt, Fabian, et al.
Publicado: (2020)

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
por: Schmidt, Fabian, et al.
Publicado: (2020)

Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion
por: Wang, Xinling, et al.
Publicado: (2020)

RETRACTED ARTICLE: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion
por: Wang, Xinling, et al.
Publicado: (2020)

Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection
por: Lan, Qiaoshuai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9vhupbao1vc6ov70htbhvcc8sn